Standard BioTools (LAB) came out with a quarterly loss of $0.04 per share in line with the Zacks Consensus Estimate. This compares to loss of$0.23 per share a year ago. These figures are adjusted for non-recurring items.A quarter ago, it was expected that this company that makes equipment to control fluids would post a loss of $0.03 per share when it actually produced a loss of$0.05, delivering a surprise of -66.67%.Over the last four quarters, the company has surpassed consensus EPS estimates just once.S ...